Showing results (51-60 of 89) with videos related to

Sort By:
Pageof 9
Annals of Hematology|May 1, 1994
Myelodysplastic syndromes in childhood: description of seven casesA Vitale, A M Testi, M L Moleti, et al.
British Journal of Haematology|January 1, 1994
Treatment of primary refractory and relapsed acute lymphoblastic leukaemia in children and adults: the GIMEMA/AIEOP experience. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Associazione Italiana Ematologìa ed Ocologia PediatricaF Giona, A M Testi, L Annino, et al.
European Journal of Haematology|February 1, 1987
Heterogeneity of TdT+, HLA-DR+ acute leukaemia: immunological, immunocytochemical and clinical evidence of lymphoid and myeloid originG Basso, M C Putti, G Catoretti, et al.
Cancer|September 15, 1993
Treatment of pediatric Hodgkin disease tailored to stage, mediastinal mass, and age. An Italian (AIEOP) multicenter study on 215 patientsV Vecchi, S Pileri, R Burnelli, et al.
Cancer|November 14, 1997
Langerhans' cell histiocytosis in adults: a clinical and therapeutic analysis of 11 patients from a single institutionF Giona, R Caruso, A M Testi, et al.
Cancer Research|August 15, 1993
Southern blot analysis of ALL-1 rearrangements at chromosome 11q23 in acute leukemiaF Lo Coco, F Mandelli, M Breccia, et al.
British Journal of Haematology|September 15, 2009
Clofarabine, cyclophosphamide and etoposide as single-course re-induction therapy for children with refractory/multiple relapsed acute lymphoblastic leukaemiaFranco Locatelli, Anna M Testi, Maria Ester Bernardo, et al.
Haematologica|March 21, 1998
A single high dose of idarubicin combined with high-dose ARA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University "La Sapienza" of RomeA M Testi, M L Moleti, F Giona, et al.
Diagnostic and Clinical Immunology|January 1, 1987
CALLA-negative, TdT- and CD7-positive acute lymphoblastic leukemia: a phenotype associated with poor prognosisG De Rossi, M A Aloe Spiriti, A Cafolla, et al.
Haematologica|December 24, 1997
A single high dose of idarubicin combined with high-dose ABA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University La Sapienza of RomeA M Testi, M L Moleti, F Giona, et al.
Pageof 9